Literature DB >> 29348153

First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension.

Cécile Daccord1, Igor Letovanec2, Patrick Yerly3, Jonathan Bloch4, Adam Ogna1, Laurent P Nicod1,5, John-David Aubert6,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29348153     DOI： 10.1183/13993003.01694-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  5 in total

1.  Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension.

Authors:  Marie-Camille Chaumais; Caroline O'Connell; Laurent Savale; Christophe Guignabert; Frédéric Perros; Xavier Jaïs; Olivier Sitbon; Marc Humbert; David Montani
Journal:  Int J Clin Pharm       Date:  2018-08-13

2.  Reversible Pulmonary Arterial Hypertension Induced by Dasatinib.

Authors:  Hsiu-Chuan Lee; Chi-Cheng Huang
Journal:  Acta Cardiol Sin       Date:  2022-09       Impact factor: 1.800

3.  Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.

Authors:  Marc Humbert; Christophe Guignabert; Sébastien Bonnet; Peter Dorfmüller; James R Klinger; Mark R Nicolls; Andrea J Olschewski; Soni S Pullamsetti; Ralph T Schermuly; Kurt R Stenmark; Marlene Rabinovitch
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

Review 4.  A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities.

Authors:  Zahra Nekoukar; Minoo Moghimi; Ebrahim Salehifar
Journal:  Blood Res       Date:  2021-12-31

5.  Melatonin Attenuates Dasatinib-Aggravated Hypoxic Pulmonary Hypertension via Inhibiting Pulmonary Vascular Remodeling.

Authors:  Rui Wang; Jinjin Pan; Jinzhen Han; Miaomiao Gong; Liang Liu; Yunlong Zhang; Ying Liu; Dingyou Wang; Qing Tang; Na Wu; Lin Wang; Jinsong Yan; Hua Li; Yuhui Yuan
Journal:  Front Cardiovasc Med       Date:  2022-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.